• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强迫症患者的 5-羟色胺 2A 受体:[11C]MDL 100907 的正电子发射断层扫描研究。

Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

机构信息

Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.

出版信息

Biol Psychiatry. 2011 Nov 1;70(9):897-904. doi: 10.1016/j.biopsych.2011.06.023.

DOI:10.1016/j.biopsych.2011.06.023
PMID:21855857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3951757/
Abstract

BACKGROUND

Serotonergic abnormalities are hypothesized to contribute to obsessive-compulsive disorder (OCD). This study used positron emission tomography with the radioligand [11C]MDL 100907 to examine whether the distribution of serotonin 2A (5-HT(2A)) receptors is altered in OCD.

METHODS

Nineteen OCD subjects, free of psychiatric medications and depression, and 19 matched healthy subjects underwent positron emission tomography scans following injection of [11C]MDL 100907. Total distribution volumes were derived by kinetic analysis using the arterial input function. Two measures of 5-HT(2A) availability were computed: the ratio at equilibrium of specifically bound radiotracer either to nondisplaceable radiotracer in tissue (BP(ND)) or to unmetabolized tracer in arterial plasma (BP(p)). Groups were compared using a region of interest (ROI) analysis and voxelwise analysis of spatially normalized parametric maps. ROIs included cortical (orbitofrontal, dorsolateral prefrontal, medial prefrontal, anterior cingulate, temporal, parietal, occipital, and insular cortex) and limbic (entorhinal cortex, parahippocampal gyrus, and medial temporal lobe) regions.

RESULTS

No significant group differences were observed in [11C]MDL 100907 BP(ND) or BP(p) in the ROIs or in the voxelwise analysis of BP(ND) maps. There was a significant correlation in the orbitofrontal cortex between [11C]MDL 100907 binding and age of onset, with earlier age of onset associated with higher binding.

CONCLUSIONS

Adults with OCD are not characterized as a group by major changes in 5-HT(2A) availability in cortical or limbic brain regions. Further research is warranted to examine potential differences in 5-HT(2A) availability between early- and late-onset OCD and to assess 5-HT(2A) function in relation to other neurotransmitter systems implicated in OCD.

摘要

背景

血清素能异常被假设与强迫症(OCD)有关。本研究使用正电子发射断层扫描技术,用放射性配体[11C]MDL 100907,研究 5-羟色胺 2A(5-HT2A)受体的分布是否在 OCD 中发生改变。

方法

19 名未服用精神药物和抑郁症的 OCD 患者和 19 名匹配的健康受试者在注射[11C]MDL 100907 后进行正电子发射断层扫描。通过使用动脉输入函数的动力学分析得出总分布体积。计算了 5-HT2A 可用性的两个指标:组织中特异性结合放射性示踪剂与不可置换放射性示踪剂(BP(ND))或动脉血浆中未代谢示踪剂(BP(p))的平衡时比值。使用感兴趣区(ROI)分析和空间归一化参数图的体素分析比较两组。ROI 包括皮质(眶额、背外侧前额、内侧前额、前扣带、颞叶、顶叶、枕叶和岛叶皮质)和边缘(内嗅皮质、海马旁回和内侧颞叶)区域。

结果

在 ROI 或 BP(ND)图的体素分析中,未观察到[11C]MDL 100907 BP(ND)或 BP(p)在 OCD 组和对照组之间存在显著差异。在眶额皮质中,[11C]MDL 100907 结合与发病年龄之间存在显著相关性,发病年龄较早与结合较高相关。

结论

OCD 成人的皮质或边缘脑区 5-HT2A 可用性无明显变化。需要进一步研究以检查早期和晚期 OCD 之间 5-HT2A 可用性的潜在差异,并评估 5-HT2A 功能与强迫症中涉及的其他神经递质系统的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/a518dc28386e/nihms-320069-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/4acc0b1dcfe6/nihms-320069-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/29e99e70f864/nihms-320069-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/a518dc28386e/nihms-320069-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/4acc0b1dcfe6/nihms-320069-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/29e99e70f864/nihms-320069-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd84/3951757/a518dc28386e/nihms-320069-f0003.jpg

相似文献

1
Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.强迫症患者的 5-羟色胺 2A 受体:[11C]MDL 100907 的正电子发射断层扫描研究。
Biol Psychiatry. 2011 Nov 1;70(9):897-904. doi: 10.1016/j.biopsych.2011.06.023.
2
Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.强迫症中的5-羟色胺转运体:一项使用[(11)C]McN 5652的正电子发射断层扫描研究
Biol Psychiatry. 2003 Dec 15;54(12):1414-21. doi: 10.1016/s0006-3223(03)00544-4.
3
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.初发强迫症患者5-羟色胺2A和多巴胺D2功能障碍的体内正电子发射断层显像研究
Neuroimage. 2008 Aug 1;42(1):306-14. doi: 10.1016/j.neuroimage.2008.04.233. Epub 2008 Apr 27.
4
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.强迫症患者岛叶皮质中 5-羟色胺转运体结合减少:一项 [11C]DASB PET 研究。
Neuroimage. 2010 Jan 1;49(1):121-6. doi: 10.1016/j.neuroimage.2009.07.069. Epub 2009 Aug 4.
5
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.在人类中对 5-羟色胺 2A(5-HT2A)受体选择性 PET 放射性示踪剂 11C-MDL100907 的扩展特征描述:定量分析、测试-重测重现性以及对内源性 5-HT 张力的敏感性。
Neuroimage. 2012 Jan 2;59(1):271-85. doi: 10.1016/j.neuroimage.2011.07.001. Epub 2011 Jul 18.
6
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.用[(11)C]MDL 100,907对人脑中5-HT(2A)受体定量的示踪动力学模型的验证
J Cereb Blood Flow Metab. 2007 Jan;27(1):161-72. doi: 10.1038/sj.jcbfm.9600323. Epub 2006 May 10.
7
Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.从抑郁症中康复的心境正常、未服用药物的患者5-HT(2A)受体结合增加:一项使用[(11)C]MDL 100,907的正电子发射研究。
Am J Psychiatry. 2006 Sep;163(9):1580-7. doi: 10.1176/ajp.2006.163.9.1580.
8
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.患有强迫症的患者尾状核中5-HT2A受体结合增加。
Int J Neuropsychopharmacol. 2005 Sep;8(3):391-401. doi: 10.1017/S1461145705005055. Epub 2005 Apr 1.
9
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.持续滥用摇头丸会导致新皮质区域 5-羟色胺传递的前突触和后突触标记物发生改变:使用 [¹¹C]DASB 和 [¹¹C]MDL 100907 的 PET 研究。
Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.
10
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.用[11C]MDL 100,907 PET 和非侵入性动力学分析简化人脑 5-HT2A 受体的定量。
Neuroimage. 2010 Apr 15;50(3):984-93. doi: 10.1016/j.neuroimage.2010.01.037. Epub 2010 Jan 18.

引用本文的文献

1
Increased Neuroplasticity in Frontal Cortex to Reduce Compulsive Behavior: A Preclinical tDCS Study in Male Rats.增加前额叶皮质的神经可塑性以减少强迫行为:一项雄性大鼠的临床前经颅直流电刺激研究
Mol Neurobiol. 2025 Jul 23. doi: 10.1007/s12035-025-05218-4.
2
Astrocyte Dysfunctions in Obsessive Compulsive Disorder: Rethinking Neurobiology and Therapeutic Targets.强迫症中的星形胶质细胞功能障碍:重新思考神经生物学与治疗靶点
J Neurochem. 2025 May;169(5):e70092. doi: 10.1111/jnc.70092.
3
Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings.

本文引用的文献

1
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.在人类中对 5-羟色胺 2A(5-HT2A)受体选择性 PET 放射性示踪剂 11C-MDL100907 的扩展特征描述:定量分析、测试-重测重现性以及对内源性 5-HT 张力的敏感性。
Neuroimage. 2012 Jan 2;59(1):271-85. doi: 10.1016/j.neuroimage.2011.07.001. Epub 2011 Jul 18.
2
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.强迫症患者岛叶皮质中 5-羟色胺转运体结合减少:一项 [11C]DASB PET 研究。
Neuroimage. 2010 Jan 1;49(1):121-6. doi: 10.1016/j.neuroimage.2009.07.069. Epub 2009 Aug 4.
3
强迫症的血清素能基础:神经影像学研究结果的系统评价与荟萃分析
Psychiatry Clin Neurosci. 2025 Feb;79(2):48-59. doi: 10.1111/pcn.13760. Epub 2024 Nov 7.
4
Progress in the application of molecular imaging in psychiatric disorders.分子成像在精神疾病中的应用进展
Psychoradiology. 2023 Oct 9;3:kkad020. doi: 10.1093/psyrad/kkad020. eCollection 2023.
5
Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction.强迫症:病因、神经病理学和认知功能障碍。
Brain Behav. 2023 Jun;13(6):e3000. doi: 10.1002/brb3.3000. Epub 2023 May 3.
6
Neurobiological outcomes of cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review.强迫症认知行为疗法的神经生物学结果:一项系统综述。
Front Psychiatry. 2022 Dec 9;13:1063116. doi: 10.3389/fpsyt.2022.1063116. eCollection 2022.
7
Differential Neurobiological Markers in Phenotype-stratified Rats Modeling High or Low Vulnerability to Compulsive Behavior: A Narrative Review.表型分层大鼠模型中对强迫行为高或低易感性的差异神经生物学标志物:综述。
Curr Neuropharmacol. 2023;21(9):1924-1933. doi: 10.2174/1570159X21666221121091454.
8
Radiotracers for the Central Serotoninergic System.中枢5-羟色胺能系统的放射性示踪剂
Pharmaceuticals (Basel). 2022 May 3;15(5):571. doi: 10.3390/ph15050571.
9
Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice.5-羟色胺2A受体阻断可减轻阿片类药物暴露小鼠中纳洛酮诱导的戒断症状的激发。
Front Behav Neurosci. 2022 Feb 9;15:797217. doi: 10.3389/fnbeh.2021.797217. eCollection 2021.
10
Pharmacotherapeutic Strategies and New Targets in OCD.强迫症的药物治疗策略和新靶点。
Curr Top Behav Neurosci. 2021;49:331-384. doi: 10.1007/7854_2020_204.
Using individual items to clarify OCD symptom structure: the case for five factors.利用单个项目来阐明强迫症症状结构:五因素的情况
Am J Psychiatry. 2009 Jun;166(6):728-9; author reply 729-31. doi: 10.1176/appi.ajp.2009.09020287.
4
Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging.儿童强迫症,一种神经发育障碍?来自神经影像学的证据。
Neurosci Biobehav Rev. 2009 Jun;33(6):818-30. doi: 10.1016/j.neubiorev.2009.01.003. Epub 2009 Jan 21.
5
Brain imaging in pediatric obsessive-compulsive disorder.小儿强迫症的脑成像
J Am Acad Child Adolesc Psychiatry. 2008 Nov;47(11):1262-72. doi: 10.1097/CHI.0b013e318185d2be.
6
Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories.强迫症协作遗传学研究中耶鲁-布朗强迫症量表维度的进一步发展:症状与类别
Psychiatry Res. 2008 Jul 15;160(1):83-93. doi: 10.1016/j.psychres.2007.07.010. Epub 2008 Jun 2.
7
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.初发强迫症患者5-羟色胺2A和多巴胺D2功能障碍的体内正电子发射断层显像研究
Neuroimage. 2008 Aug 1;42(1):306-14. doi: 10.1016/j.neuroimage.2008.04.233. Epub 2008 Apr 27.
8
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.阿立哌唑对精神分裂症患者纹状体及纹状体以外区域多巴胺D2受体的剂量-占有率研究:PET及[18F]氟哌利多显像
Neuropsychopharmacology. 2008 Dec;33(13):3111-25. doi: 10.1038/npp.2008.33. Epub 2008 Apr 16.
9
Consensus nomenclature for in vivo imaging of reversibly binding radioligands.可逆结合放射性配体体内成像的共识命名法。
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. doi: 10.1038/sj.jcbfm.9600493. Epub 2007 May 9.
10
Taboo thoughts and doubt/checking: a refinement of the factor structure for obsessive-compulsive disorder symptoms.禁忌思维与怀疑/检查:强迫症症状因子结构的细化
Psychiatry Res. 2007 Jun 30;151(3):255-8. doi: 10.1016/j.psychres.2006.09.005. Epub 2007 Mar 21.